Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,322 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00212069 | Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer | completed | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00698659 | Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies | terminated | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 |
| clinicaltrials |
| NCT00717002 | Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00717847 | A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01100827 | A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01100840 | A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01130584 | Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01570439 | To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore | unknown | — | 10 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01596361 | Verification of a Pharmacogenetic Approach to Customizing Chemotherapy to Asians | unknown | — | 750 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01596374 | Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours | unknown | — | 2,000 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01596439 | A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients | unknown | — | 100 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01619306 | Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients | unknown | — | 850 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01619358 | Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma | unknown | — | 150 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01619501 | Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01619514 | Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass Spectrometry | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01719341 | Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia | unknown | — | 21 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01866202 | Study of Circulating and Tumor Biomarkers in Breast Cancer Patients | unknown | — | 100 | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00416130 | Clinical Trial of SAHA in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00669773 | Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient | unknown | Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00697437 | Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | completed | Phase 2 | 10 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00809237 | Hydroxychloroquine and Gefitinib to Treat Lung Cancer | unknown | Phase 1 / Phase 2 | 71 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01482754 | Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma | completed | N/A | 30 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01596452 | Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology | unknown | — | 31 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01866631 | Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre | unknown | — | 2,000 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00721123 | A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis | completed | Phase 3 | 538 | Hoffmann-La RocheINDUSTRY | 17 | Nov 28, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT01096030 | Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors | completed | Phase 1 | 33 | BayerINDUSTRY | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT00870532 | Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 1 | 52 | National Cancer Centre, SingaporeOTHER | 1 | Nov 4, 2013 | clinicaltrials |
| NCT00027768 | Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer | unknown | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00041275 | Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 10 | Sep 20, 2013 | clinicaltrials |
| NCT00956436 | Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 40 | BiogenINDUSTRY | 4 | Sep 16, 2013 | clinicaltrials |
| NCT01204177 | Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) | completed | Phase 2 | 70 | BayerINDUSTRY | 4 | Sep 6, 2013 | clinicaltrials |
| NCT00007930 | Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer | unknown | Phase 3 | 800 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 2 | Aug 26, 2013 | clinicaltrials |
| NCT00862082 | Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 1 / Phase 2 | 14 | Proacta, IncorporatedINDUSTRY | 4 | Aug 23, 2013 | clinicaltrials |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 34 | Aug 21, 2013 | clinicaltrials |
| NCT00690430 | Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease | completed | Phase 3 | 186 | Novartis PharmaceuticalsINDUSTRY | 16 | Jul 30, 2013 | clinicaltrials |
| NCT01168791 | Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma(PICASSO III) | completed | Phase 3 | 447 | Alaunos TherapeuticsINDUSTRY | 21 | Jul 18, 2013 | clinicaltrials |
| NCT00003424 | Tamoxifen in Treating Patients With Primary Liver Cancer | completed | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 6 | Jun 26, 2013 | clinicaltrials |
| NCT00589238 | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 16 | National Cancer Centre, SingaporeOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00467194 | Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 27 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01736410 | A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | completed | Phase 2 | 30 | National Cancer Centre, SingaporeOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT01867073 | A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours | unknown | — | 20 | National University Hospital, SingaporeOTHER | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00062257 | Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | — | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00077402 | Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | Cancer Therapeutics Research GroupOTHER | 3 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT01394315 | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer(DOT) | terminated | — | 8 | National Cancer Centre, SingaporeOTHER | 1 | May 3, 2013 | clinicaltrials |
| NCT00716534 | Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 145 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Apr 29, 2013 | clinicaltrials |
| NCT01837511 | Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients | completed | — | 377 | GlaxoSmithKlineINDUSTRY | 2 | Apr 23, 2013 | clinicaltrials |
| NCT00517790 | Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | AbbVie (prior sponsor, Abbott)INDUSTRY | 5 | Apr 5, 2013 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials